GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Pre-Tax Income

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Pre-Tax Income : ¥213 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Harbin Gloria Pharmaceuticals Co's pretax income for the three months ended in Mar. 2024 was ¥68 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥213 Mil. Harbin Gloria Pharmaceuticals Co's pretax margin was 11.53%.

During the past 13 years, Harbin Gloria Pharmaceuticals Co's highest Pretax Margin was 30.80%. The lowest was -51.53%. And the median was 9.47%.


Harbin Gloria Pharmaceuticals Co Pre-Tax Income Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Pre-Tax Income Chart

Harbin Gloria Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,604.14 565.12 85.97 -269.68 176.78

Harbin Gloria Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.01 19.37 208.82 -83.42 68.41

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Gloria Pharmaceuticals Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Pre-Tax Income falls into.



Harbin Gloria Pharmaceuticals Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Harbin Gloria Pharmaceuticals Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=246.135+0+-42.654+18.474+-45.177
=177

Harbin Gloria Pharmaceuticals Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=79.958+0+-5.239+-3.832+-2.473
=68

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥213 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harbin Gloria Pharmaceuticals Co  (SZSE:002437) Pre-Tax Income Explanation

Harbin Gloria Pharmaceuticals Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=68.414/593.133
=11.53%

During the past 13 years, Harbin Gloria Pharmaceuticals Co's highest Pretax Margin was 30.80%. The lowest was -51.53%. And the median was 9.47%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harbin Gloria Pharmaceuticals Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Traded in Other Exchanges
N/A
Address
Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Executives
Guo Yun Pei Independent director
Wang Yu Supervisors
Yang Hong Bing Director
Diao Xiu Qiang Directors, executives
Liu Yue Yin Securities Affairs Representative
Guo Lei Feng Directors, Directors, and Executives
Li Jun Ling Director
Yang Hai Feng Executives
Zhang Su Mei Supervisors
Zhu Ji Man Director

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines